Article
Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer.
Biomolecules - 6 Apr 2022
Zhang Shengliang, Carlsen Lindsey, Hernandez Borrero Liz, Seyhan Attila A, Tian Xiaobing, El-Deiry Wafik S
Abstract excerpt
TP53 is a tumor suppressor gene that encodes a sequence-specific DNA-binding transcription factor activated by stressful stimuli; it upregulates target genes involved in growth suppression, cell death, DNA repair, metabolism, among others. TP53 is the most frequently mutated gene in tumors, with mutations not only leading to loss-of-function (LOF), but also gain-of-function (GOF) that promotes tumor progression,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
